Please login to the form below

Not currently logged in
Email:
Password:

pegaspargase

This page shows the latest pegaspargase news and features for those working in and with pharma, biotech and healthcare.

SMC approves Opdivo combo as first-line skin cancer treatment

SMC approves Opdivo combo as first-line skin cancer treatment

The regulator also accepted Baxalta's Oncaspar (pegaspargase) for NHS use, approving the drug as part of an antineoplastic combination therapy for paediatric and adult patients with acute lymphoblastic leukaemia.

Latest news

More from news
Approximately 2 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Deal Watch July 2016 Deal Watch July 2016

    Pfenex is a biosimilars company, and the agreement with Jazz also includes rights to a recombinant pegaspargase candidate.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics